ICM
ACHC icon

Invenomic Capital Management’s Acadia Healthcare ACHC Stock Holding History

Invenomic Capital Management’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,182,331
Closed -$27.7M – 117
2026
Q1 		$27.7M Sell
1,182,331
-2,129,712
-64% -$38.6M 1.27% 26
2025
Q4 		$47M Buy
3,312,043
+1,375,647
+71% +$26M 2.19% 7
2025
Q3 		$47.9M Buy
1,936,396
+568,796
+42% +$12.7M 2.32% 7
2025
Q2 		$31M Buy
1,367,600
+1,295,821
+1,805% +$30.7M 1.76% 12
2025
Q1 		$2.18M Buy
+71,779
New +$2.73M 0.11% 150

Other funds holding ACHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $5.77B AUM 89.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

Invenomic Capital Management's ACHC Position: Q2 2026 in Review

Invenomic Capital Management sold out of Acadia Healthcare (ACHC) in Q2 2026, closing a stake of 1,182,331 shares — an estimated $27.7M sold.

Invenomic Capital Management first reported a position in ACHC in Q1 2025 and held it in 5 quarters. The position peaked at $47.9M in Q3 2025. 313 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • Invenomic Capital Management reported no remaining Acadia Healthcare position as of Q2 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 1,182,331 Acadia Healthcare shares in Q2 2026, an estimated $27.7M.
  • Invenomic Capital Management first reported a position in Acadia Healthcare in Q1 2025 and held it in 5 quarters.
  • Invenomic Capital Management's Acadia Healthcare position peaked at $47.9M in Q3 2025.
  • 313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.